Clinician to CEO : Export Your Medical Device With Confidence By Overcoming Go To Market Roadblocks For Medtech Growth

If an overseas distributor approached you tomorrow wanting to sell your MedTech product, how would you decide whether that market was worth entering?

An unexpected enquiry from an overseas distributor can feel like an exciting opportunity to grow your MedTech business internationally. But distributor interest alone doesn't tell you whether the market is commercially attractive, whether it's the right priority or what it will take to succeed there. In this episode, Hakeem shares a real client scenario and explains why successful MedTech exporting requires a deliberate market entry strategy rather than simply reacting to opportunities as they appear.

In this episode you'll discover:

• Why interest from an overseas distributor doesn't automatically mean you've found the right export market for your MedTech product.
• How to evaluate potential export markets by considering market opportunity, growth potential, competition, regulatory requirements and commercial viability.
• How asking where, which and how can help you prioritise export markets and understand what it will take to succeed before committing your resources.

Listen now to discover how to evaluate unexpected MedTech export opportunities, choose the markets worth pursuing and make more confident international market entry decisions.

Book a 30min Healthcare Export Accelerator discovery call

Connect with me on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Before spending thousands on your next MedTech export exhibition, how do you know whether it's actually worth the investment?

International exhibitions can be a valuable part of your MedTech export strategy, whether you're looking for distributors, entering new markets or growing existing sales. But attending the same exhibitions year after year doesn't necessarily mean they're delivering commercial value. In this episode, Hakeem explores why exhibitions should be treated as a deliberate commercial investment, how to decide whether they're the right activity for your business, and why measuring their return should start before you book the stand.

In todays episode you'll discover:

• Why attending the same MedTech exhibitions year after year, or simply because your competitors are there, doesn't necessarily make them the right investment for your export business.
• How to decide whether an exhibition supports your commercial objectives, whether that's finding distributors, entering new export markets or generating more sales from existing customers.
• Why defining what success looks like and how you'll measure it before booking an exhibition can help you understand its true return on investment and make better decisions about your export budget.

Listen now to discover how to evaluate your next MedTech export exhibition, measure its commercial value and make more informed decisions about where to invest your time and money to grow your international business.

Book a 30min Healthcare Export Accelerator discovery call

Connect with me on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

When choosing an export distributor for your MedTech product, is bigger always better?

Finding a distributor with a large sales team, an established customer base and an impressive portfolio can look like the safest route into an export market. But size doesn't necessarily mean your MedTech product will get the attention, commitment or resources it needs. In this episode, Hakeem speaks with Beau Zorn about what really matters when selecting an export distributor—and why the right partner may not be the biggest name in the market.

In this episode you'll discover:

• Why a large MedTech export distributor with an extensive portfolio may not always give your product the focus and commitment it needs.
• What to look for beyond distributor size, including portfolio fit, market relationships, commercial commitment and their ability to build a compelling business case for your product.
• Why MedTech companies need to understand the export market themselves and demonstrate how they'll support the distributor rather than expecting them to build the market alone.

Listen now to discover how to choose a MedTech export distributor that will prioritise your product and give you a stronger chance of commercial success in your target market.

Book a 30min Healthcare Export Accelerator discovery call

Connect with me on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

If so many MedTech companies still struggle to achieve commercial success in export markets, are we asking the right question about why?

MedTech companies have access to more market intelligence, better technology, stronger data and more commercial expertise than ever before. Yet innovative medical devices with regulatory approval, clinical evidence and significant investment can still struggle to achieve meaningful commercial success in export markets. In this episode, Hakeem asks whether the problem is really how well companies execute their commercialisation strategy—or whether it's time to question the playbook itself.

In this episode you'll discover:

• Why regulatory approval, clinical evidence and even a great MedTech product don't necessarily translate into commercial success when entering export markets.
• Why choosing markets, appointing distributors and building sales teams based on assumptions and previous experience can lead to expensive commercialisation mistakes.
• How starting with the conditions required for customer adoption—and working backwards—can help you build a more systematic MedTech export commercialisation strategy.

Listen now to discover why rethinking the traditional MedTech export commercialisation playbook could help you build a clearer route from regulatory approval to customer adoption and commercial success.

Book a 30min Healthcare Export Accelerator discovery call

Connect with me on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Could asking your MedTech export distributors for less actually help you get better performance from them?

When you want better performance from your export distributors, it's tempting to ask for more reports, KPIs, forecasts, CRM updates and meetings. But distributors are often managing multiple manufacturer relationships, and adding more administration doesn't necessarily give you better visibility or improve results. In this episode, Hakeem explores why simplifying what you ask your distributors to report could lead to better information, stronger commercial conversations and a more productive relationship.

What you'll discover in this episode:

• Why asking your MedTech export distributors for more data and reporting doesn't necessarily give you better visibility into what's happening in your export markets.
• How focusing on just five key metrics can give you the commercial information you need without overwhelming distributors with unnecessary administration.
• How simpler reporting can help turn distributor meetings from chasing updates into more valuable conversations about performance, challenges and where you can help them improve results.

Listen now to discover how asking your MedTech export distributors for less could give you better visibility, stronger commercial conversations and ultimately help you improve performance in your export markets.

Watch the Distributor Hub in Action

Message me via DM on Linkedin

This podcast is for clinicians feeling stuck in turning medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, and to scale up their international sales in MedTech.

What if there were a clearer route for taking your MedTech product from NHS evaluation to adoption and wider scale?

Getting your MedTech product successfully evaluated in the NHS doesn't automatically create a route to market. The harder challenge is turning that evidence into procurement, funding, routine adoption and eventually wider NHS scale. In this episode, Hakeem explores the newly announced Manchester Sandbox, why its ambition could help bridge this commercialisation gap, and the questions that still need answering.

In this episode you'll discover:

• What the Manchester Sandbox is and why MedTech companies looking to enter or grow within the NHS should be paying attention.
• How its ambition to connect real-world NHS evaluation with adoption could potentially create a clearer route to market for promising medical technologies.
• What still needs to happen after a successful evaluation if the Sandbox is going to help MedTech companies move beyond one NHS Trust and achieve wider adoption and scale.

Listen now to discover whether the Manchester Sandbox could create a clearer route to market for MedTech companies trying to turn successful NHS evaluations into adoption and wider scale.

Book a 30min Healthcare Export Accelerator discovery call

Message me via DM on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

If your NHS clinical trial is successful, do you already know what needs to happen next for your MedTech product to actually get adopted?

Getting an NHS clinician interested in trialling your MedTech product can feel like a major commercial milestone. But the trial itself isn't the end goal. Before committing to a start date, you need to understand the stakeholders, approvals and processes involved—and have a credible pathway from a successful pilot to funding, procurement and routine adoption.

By listening you'll discover:

• Why mapping NHS stakeholders, approvals and governance requirements before committing to a trial can prevent delays later.
• How MedTech companies can better support their clinical champion by preparing the evidence, documentation and information they'll need to navigate the organisation.
• Why working backwards from adoption can help you identify the funding, procurement and buying pathway before you invest time and money in the trial.

Listen now to discover how working backwards from NHS adoption can help you plan a clinical trial that has a clearer commercial pathway beyond the pilot.

Book a 30min Healthcare Export Accelerator discovery call

Message me via DM on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

How do you get an NHS clinician to trial your MedTech product and then turn that clinical interest into adoption?

If you're trying to commercialise a MedTech product or export a medical device into the UK, getting NHS clinicians interested is only one part of the challenge. You need to understand how to approach clinicians, what makes them willing to evaluate a new technology, and what needs to happen inside the wider NHS organisation for that initial interest to progress towards procurement and adoption.

In this episode you'll discover:

• What actually happens inside an NHS Trust when a MedTech company wants to run a clinical trial or pilot, including the stakeholders, governance, evidence and approvals that may need to be considered.
• Why clinician enthusiasm alone doesn't guarantee organisational approval and how procurement, funding, IT, cybersecurity, workflow and operational considerations can influence whether your medical device progresses.
• How to prepare for what happens after a successful trial so there is a credible pathway towards funding, procurement, adoption and routine clinical use rather than treating the pilot itself as the end goal.

Listen now to understand what really happens inside an NHS Trust after a clinician shows interest in your MedTech product—and how to prepare for the journey from clinical trial to adoption.

Book a 30min Healthcare Export Accelerator discovery call

Message me via DM on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

When exporting your MedTech product to Europe, should you focus everything on one market first or test several countries at the same time?

That's exactly the unresolved question. We're not telling them the answer.

Choosing where to start in Europe isn't simply about finding the country with the biggest MedTech market. Different countries can have very different reimbursement pathways, adoption barriers, competition, KOL support and routes to market. In this Decision Point episode, Hakeem revisits his conversation with Laurent Laffineur to explore whether your European export strategy should focus on one market, test several carefully selected countries, or start somewhere smaller where you can prove your commercial model before scaling.

In this episode you'll discover:

• Why the biggest European MedTech market isn't automatically the best place to invest your export budget first.
• The advantages of testing your go-to-market strategy across two or three carefully selected European markets rather than assuming success in one country can simply be duplicated elsewhere.
• How customer access, adoption barriers, competition, KOL relationships and the cost of proving commercial traction can help you decide where to concentrate your investment.

Listen now to discover how to approach your first European export markets and decide where to invest your MedTech go-to-market budget before committing significant resources to expansion.

Book a 30min Healthcare Export Accelerator discovery call

Message me via DM on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

If you're planning to export your MedTech product to Europe, how do you decide which countries you should actually enter first?

This doesn't assume they're making a mistake. It poses the central decision the episode helps them make.

Europe may look like one export opportunity on a map, but the commercial reality can be very different from country to country. Reimbursement, clinician adoption, buying pathways, language, culture and routes to market can all change as you cross a border. In this episode, Hakeem speaks with Laurent Laffineur, founder of Prime MedTech, about how to build a European go-to-market strategy, prioritise the right export markets and start commercial preparation before you're ready to launch.

On todays episode you'll discover:

• How to prioritise European export markets based on the factors that matter for your specific MedTech product rather than simply choosing the biggest countries.
• Why reimbursement, KOL support, clinician adoption, language, culture and available budget can dramatically change where your best European opportunities are.
• Why your European commercialisation and go-to-market work should begin during the regulatory process rather than waiting until you've received EU MDR approval and want to launch immediately.

Listen now to learn how to choose the right European export markets for your MedTech product and build your go-to-market strategy before committing significant time and money to launch.

Book a 30min Healthcare Export Accelerator discovery call

Message me via DM on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.